Technology Addiction — Health Problems Caused by Technology Addiction in Preschool Children
Citation(s)
Franjoine MR, Gunther JS, Taylor MJ Pediatric balance scale: a modified version of the berg balance scale for the school-age child with mild to moderate motor impairment. Pediatr Phys Ther. 2003 Summer;15(2):114-28. doi: 10.1097/01.PEP.0000068117.48023.18.
Howie EK, Coenen P, Campbell AC, Ranelli S, Straker LM Head, trunk and arm posture amplitude and variation, muscle activity, sedentariness and physical activity of 3 to 5 year-old children during tablet computer use compared to television watching and toy play. Appl Ergon. 2017 Nov;65:41-50. doi: 10.1016/j.apergo.2017.05.011. Epub 2017 Jun 7.
Kobel S, Henle L, Laemmle C, Wartha O, Szagun B, Steinacker JM Intervention Effects of a Kindergarten-Based Health Promotion Programme on Motor Abilities in Early Childhood. Front Public Health. 2020 Jun 30;8:219. doi: 10.3389/fpubh.2020.00219. eCollection 2020.
Taylor NF, Dodd KJ, Graham HK Test-retest reliability of hand-held dynamometric strength testing in young people with cerebral palsy. Arch Phys Med Rehabil. 2004 Jan;85(1):77-80. doi: 10.1016/s0003-9993(03)00379-4.
Evaluation of the Relationship Between Technology Addiction and Posture Disorder, Balance and Muscle Strength in Preschool Children
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
